Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndrome
about
Investigational drugs to treat methicillin-resistant Staphylococcus aureusThe staphylococcal enterotoxin (SE) family: SEB and siblingsFine-mapping of immunodominant linear B-cell epitopes of the Staphylococcus aureus SEB antigen using short overlapping peptides.An Update on Clinical Burden, Diagnostic Tools, and Therapeutic Options of Staphylococcus aureusIsotype switching increases efficacy of antibody protection against staphylococcal enterotoxin B-induced lethal shock and Staphylococcus aureus sepsis in mice.Detection and measurement of staphylococcal enterotoxin-like K (SEl-K) secretion by Staphylococcus aureus clinical isolates.Humanized staphylococcal enterotoxin B (SEB)-specific monoclonal antibodies protect from SEB intoxication and Staphylococcus aureus infections alone or as adjunctive therapy with vancomycinA tripartite cocktail of chimeric monoclonal antibodies passively protects mice against ricin, staphylococcal enterotoxin B and Clostridium perfringens epsilon toxinMechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodiesCD4+ T cells promote the pathogenesis of Staphylococcus aureus pneumonia.Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1.Multiple B-cell epitope vaccine induces a Staphylococcus enterotoxin B-specific IgG1 protective response against MRSA infectionImmunisation With Immunodominant Linear B Cell Epitopes Vaccine of Manganese Transport Protein C Confers Protection against Staphylococcus aureus Infection.Protective Efficacy and Mechanism of Passive Immunization with Polyclonal Antibodies in a Sepsis Model of Staphylococcus aureus Infection.Sublethal staphylococcal enterotoxin B challenge model in pigs to evaluate protection following immunization with a soybean-derived vaccine.Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway.Toxigenic profile of methicillin-sensitive and resistant Staphylococcus aureus isolated from special groupsAntibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections.Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the ebola virus envelope glycoprotein.Bacterial Toxins-Staphylococcal Enterotoxin B.Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.Adaptive Immunity Against Staphylococcus aureus.FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights.Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.Hydroponic Treatment of Nicotiana benthamiana with Kifunensine Modifies the N-glycans of Recombinant Glycoprotein Antigens to Predominantly Man9 High-Mannose Type upon Transient Overexpression.Near infrared fluorescence imaging of EGFR expression in vivo using IRDye800CW-nimotuzumab.
P2860
Q26780246-CB1BA634-DA4A-4CF6-985C-F4DD3DCD7797Q26830220-7351EC84-B3BA-462E-995C-70E79F963857Q31153075-FEC303A0-2292-4786-9FD9-2E6D5C428774Q33723258-F561706B-8C48-43E6-8FD8-801022AB0D8BQ33751822-0A7FFEB5-41A6-4F69-9923-4BE479F4A6C3Q33899955-4A8D21E3-E4F7-4A8A-88CB-073A6C413F29Q34315661-3689BFE7-1487-44A3-91EA-E65B7FF05FB8Q34588890-1D1B310B-E91E-448E-BF67-692A42C353E0Q35172579-99644E4D-633A-483E-A5A8-28B0193933DCQ35474220-E59B6634-5921-45E0-A51C-AD8DB7CC0D56Q35602977-E6EB601B-5BB4-49AA-9458-B7944B48FBEBQ35880774-EA7490B8-2148-4097-950B-FC8F84928186Q35928634-26AA4A36-2B70-4771-A279-470EF5300EF8Q36188542-5220B00E-DBC5-4AB4-A065-D7C052B385D7Q36504844-368D65FB-0DD6-45E9-883B-3710079A9C76Q36577139-CFAEFF84-DAEF-485A-8E22-8265DBFDF583Q36583903-9CA589B3-4477-4373-8607-ACB52DEF58D9Q36609408-0C0C28E0-CD5B-49C8-8E18-02614EEE7BEAQ36934038-51963BF1-DA0A-4D7C-93F6-8E0D80F1F0EDQ37378451-C3B70756-505C-4DAA-BB5A-A694B68CCDA5Q38674449-B444072F-C159-4909-9D7D-8D55AB6381DDQ38751767-C39A2507-6644-4D84-86FE-045A7548159FQ39301452-47C1DC7E-D9B3-4347-9609-7C445F02A362Q40420550-702165D6-B382-4B1F-BB08-8CCDA45B768BQ49470037-D1A4165C-C28D-41DD-AE9D-1F209E117BA2Q49787562-474FB224-3214-48BF-99EF-E5E9A7B6F941
P2860
Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndrome
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Synthetic human monoclonal ant ...... e against toxic shock syndrome
@ast
Synthetic human monoclonal ant ...... e against toxic shock syndrome
@en
type
label
Synthetic human monoclonal ant ...... e against toxic shock syndrome
@ast
Synthetic human monoclonal ant ...... e against toxic shock syndrome
@en
prefLabel
Synthetic human monoclonal ant ...... e against toxic shock syndrome
@ast
Synthetic human monoclonal ant ...... e against toxic shock syndrome
@en
P2093
P2860
P356
P1476
Synthetic human monoclonal ant ...... e against toxic shock syndrome
@en
P2093
Atefeh R Boroun
Eric Stavale
Hatice Karauzum
Kelly L Warfield
Larry Zeitlin
Laura Abaandou
M Javad Aman
Mahta Mahmoudieh
Sachdev S Sidhu
Sergey Shulenin
P2860
P304
25203-25215
P356
10.1074/JBC.M112.364075
P407
P577
2012-05-29T00:00:00Z